7.1.2 When to start ART in pregnant and breastfeeding women
Consolidated ARV guidelines, June 2013
- All pregnant and breastfeeding women with HIV should initiate triple ARVs (ART), which should be maintained at least for the duration of mother-to-child transmission risk. Women meeting treatment eligibility criteria should continue lifelong ART (strong recommendation, moderate quality evidence).
- For programmatic and operational reasons, particularly in generalized epidemics, all pregnant and breastfeeding women with HIV should initiate ART as lifelong treatment (conditional recommendation, low-quality evidence).
- In some countries, for women who are not eligible for ART for their own health, consideration can be given to stopping the ARV regimen after the period of mother-to-child transmission risk has ceased (conditional recommendation, low-quality evidence).